Key result
Positive Cornell product on ECG linked to ~5-fold higher 15-year cardiovascular risk in hypertensive LVH.
Why the study?
It is necessary to know the probable outcome for patients during hypertension treatment to improve cardiovascular event prevention, testing whether specific ECG LVH criteria can predict outcomes.
Do specific electrocardiographic criteria for left ventricular hypertrophy predict composite cardiovascular events in hypertensive patients with echocardiographic LVH?
Cohort (n=83)
No
Do specific electrocardiographic criteria for left ventricular hypertrophy predict composite cardiovascular events in hypertensive patients with echocardiographic LVH?
In hypertensive patients with echocardiographic left ventricular hypertrophy, a positive Cornell product on ECG is a strong independent predictor of long-term cardiovascular events.
May aid risk stratification by ECG in hypertensive LVH; hypothesis-generating and should not yet change practice.
Background Electrocardiography is the first‐choice technique for detecting left ventricular hypertrophy in patients with arterial hypertension. It is necessary to know the probable outcome for every patient during the treatment, with the aim of improving cardiovascular event prevention. Hypothesis Certain electrocardiographic criteria for left ventricular hypertrophy may predict outcomes of patients with left ventricular hypertrophy during a 15‐year follow‐up. Methods Fifteen‐year prospective study of 83 consecutive patients (53 male and 30 female; mean age 55.3 ± 8.1) with echocardiographic left ventricular hypertrophy (left ventricular mass index 170.3 ± 31.6 g/m 2 ). Electrocardiographic left ventricular hypertrophy was determined by means of Gubner‐Ungerleider voltage, Lewis voltage, voltage of R wave in aVL lead, Lyon‐Sokolow voltage, Cornell voltage and Cornell product, voltage RV 6 and RV 5 ratio, Romhilt‐Estes score, Framingham criterion and Perugia criterion. Results One or more composite events were registered in 32 (38.5%) patients during 15‐year follow‐up. Positive Lyon‐Sokolow score (17.6% vs. 47.3%; P < 0.05), Lewis voltage (9.8% vs. 21.9%; P < 0.05), Cornell voltage (15.7% vs. 37.5%; P < 0.05), and Cornell product (9.8% vs. 34.4%; P < 0.01) were more frequent in a group of patients with composite events. Odd ratio for Cornell product was 4.819 (95% CI 1.486‐15.627). Conclusion Patients with echocardiographic left ventricular hypertrophy who had positive Lewis voltage, Lyon‐Sokolow voltage, Cornell voltage, and Cornell product showed worse 15‐year outcome. The strongest predictor of cardiovascular events was positive result of Cornell product.
No takes yet. Share an insight, caveat, or question.
Djordjević et al. (2020) conducted a cohort in Arterial hypertension with left ventricular hypertrophy (n=83). Positive Cornell product vs. Negative Cornell product was evaluated on Composite cardiovascular events (OR 4.819, 95% CI 1.486-15.627, p=<0.01). A positive Cornell product on electrocardiography strongly predicted composite cardiovascular events over 15 years in hypertensive patients with left ventricular hypertrophy (OR 4.819).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: